Regulation of CCL2/MCP-1 production in astrocytes by desipramine and atomoxetine: Involvement of α2 adrenergic receptors

Brain Research Bulletin

Volumn 86, Issue 5-6, 2011, Pages 326-333

  Hinojosa, Ara E ^a   García Bueno, Borja ^a   Leza, Juan C ^a   Madrigal, José L M ^a  

^a SCHOOL OF MEDICINE   (Spain)

Author keywords

Astrocytes; Atomoxetine; CCL2; Desipramine; MCP 1; Noradrenaline

Indexed keywords

ALPHA 2 ADRENERGIC RECEPTOR; ATOMOXETINE; CLONIDINE; CYCLIC AMP; DESIPRAMINE; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 12P40; MESSENGER RNA; MONOCYTE CHEMOTACTIC PROTEIN 1; NORADRENALIN; YOHIMBINE;

ALPHA ADRENERGIC RECEPTOR BLOCKING; ALPHA ADRENERGIC STIMULATION; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; ASTROCYTE; CONTROLLED STUDY; DRUG MECHANISM; GENE EXPRESSION; IN VITRO STUDY; NERVE CELL CULTURE; NONHUMAN; NORADRENALIN BRAIN LEVEL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SYNTHESIS; RAT; SIGNAL TRANSDUCTION;

ADRENERGIC ALPHA-2 RECEPTOR AGONISTS; ADRENERGIC ALPHA-2 RECEPTOR ANTAGONISTS; ADRENERGIC BETA-AGONISTS; ADRENERGIC UPTAKE INHIBITORS; ANIMALS; ASTROCYTES; CELLS, CULTURED; CHEMOKINE CCL2; CLONIDINE; CYCLIC AMP; DESIPRAMINE; ISOPROTERENOL; NOREPINEPHRINE; PROPYLAMINES; RATS; RATS, WISTAR; RECEPTORS, ADRENERGIC, ALPHA-2; YOHIMBINE;

EID: 82755197584     PISSN: 03619230     EISSN: 18732747     Source Type: Journal    
DOI: 10.1016/j.brainresbull.2011.09.014     Document Type: Article

References (62)

1. Babcock A.A., Kuziel W.A., Rivest S., Owens T. Chemokine expression by glial cells directs leukocytes to sites of axonal injury in the CNS. J. Neurosci. 2003, 23:7922-7930.
2. Backstrom I.T., Ross S.B., Marcusson J.O. [3H]desipramine binding to rat brain tissue: binding to both noradrenaline uptake sites and sites not related to noradrenaline neurons. J. Neurochem. 1989, 52:1099-1106.
3. Baldwin A.S. The NF-kappa B and I kappa B proteins: new discoveries and insights. Annu. Rev. Immunol. 1996, 14:649-683.
4. Belmadani A., Tran P.B., Ren D., Miller R.J. Chemokines regulate the migration of neural progenitors to sites of neuroinflammation. J. Neurosci. 2006, 26:3182-3191.
5. Bondareff W., Mountjoy C.Q., Roth M. Selective loss of neurones of origin of adrenergic projection to cerebral cortex (nucleus locus coeruleus) in senile dementia. Lancet 1981, 1:783-784.
6. Bruno V., Copani A., Besong G., Scoto G., Nicoletti F. Neuroprotective activity of chemokines against N-methyl-d-aspartate or beta-amyloid-induced toxicity in culture. Eur. J. Pharmacol. 2000, 399:117-121.
7. Bymaster F.P., Katner J.S., Nelson D.L., Hemrick-Luecke S.K., Threlkeld P.G., Heiligenstein J.H., Morin S.M., Gehlert D.R., Perry K.W. Atomoxetine increases extracellular levels of norepinephrine and dopamine in prefrontal cortex of rat: a potential mechanism for efficacy in attention deficit/hyperactivity disorder. Neuropsychopharmacology 2002, 27:699-711.
8. Checkley S.A., Slade A.P., Shur E., Dawling S. A pilot study of the mechanism of action of desipramine. Br. J. Psychiatry 1981, 138:248-251.
9. Cohen R.I., Almazan G. Norepinephrine-stimulated PI hydrolysis in oligodendrocytes is mediated by alpha 1A-adrenoceptors. Neuroreport 1993, 4:1115-1118.
10. Conductier G., Blondeau N., Guyon A., Nahon J.L., Rovere C. The role of monocyte chemoattractant protein MCP1/CCL2 in neuroinflammatory diseases. J. Neuroimmunol. 2010, 224:93-100.
11. Daly C., Rollins B.J. Monocyte chemoattractant protein-1 (CCL2) in inflammatory disease and adaptive immunity: therapeutic opportunities and controversies. Microcirculation 2003, 10:247-257.
12. Deshmane S.L., Kremlev S., Amini S., Sawaya B.E. Monocyte chemoattractant protein-1 (MCP-1): an overview. J. Interferon Cytokine Res. 2009, 29:313-326.
13. Eugenin E.A., D'Aversa T.G., Lopez L., Calderon T.M., Berman J.W. MCP-1 (CCL2) protects human neurons and astrocytes from NMDA or HIV-tat-induced apoptosis. J. Neurochem. 2003, 85:1299-1311.
14. Feinstein D.L., Heneka M.T., Gavrilyuk V., Dello R.C., Weinberg G., Galea E. Noradrenergic regulation of inflammatory gene expression in brain. Neurochem. Int. 2002, 41:357-365.
15. Finzer P., Soto U., Delius H., Patzelt A., Coy J.F., Poustka A., zur H.H., Rosl F. Differential transcriptional regulation of the monocyte-chemoattractant protein-1 (MCP-1) gene in tumorigenic and non-tumorigenic HPV 18 positive cells: the role of the chromatin structure and AP-1 composition. Oncogene 2000, 19:3235-3244.
16. Flugel A., Hager G., Horvat A., Spitzer C., Singer G.M., Graeber M.B., Kreutzberg G.W., Schwaiger F.W. Neuronal MCP-1 expression in response to remote nerve injury. J. Cereb. Blood Flow Metab. 2001, 21:69-76.
17. Galasso J.M., Liu Y., Szaflarski J., Warren J.S., Silverstein F.S. Monocyte chemoattractant protein-1 is a mediator of acute excitotoxic injury in neonatal rat brain. Neuroscience 2000, 101:737-744.
18. Ghirnikar R.S., Lee Y.L., He T.R., Eng L.F. Chemokine expression in rat stab wound brain injury. J. Neurosci. Res. 1996, 46:727-733.
19. Giaroni C., Canciani L., Zanetti E., Giuliani D., Pisani R., Oldrini R., Moro E., Trinchera M., Crema F., Lecchini S., Frigo G. Effects of chronic desipramine treatment on alpha2-adrenoceptors and mu-opioid receptors in the guinea pig cortex and hippocampus. Eur. J. Pharmacol. 2008, 579:116-125.
20. Gittins R.A., Harrison P.J. A morphometric study of glia and neurons in the anterior cingulate cortex in mood disorder. J. Affect. Disord. 2011.
21. Glabinski A.R., Balasingam V., Tani M., Kunkel S.L., Strieter R.M., Yong V.W., Ransohoff R.M. Chemokine monocyte chemoattractant protein-1 is expressed by astrocytes after mechanical injury to the brain. J. Immunol. 1996, 156:4363-4368.
22. Harkness K.A., Sussman J.D., vies-Jones G.A., Greenwood J., Woodroofe M.N. Cytokine regulation of MCP-1 expression in brain and retinal microvascular endothelial cells. J. Neuroimmunol. 2003, 142:1-9.
23. Heneka M.T., Galea E., Gavriluyk V., Dumitrescu-Ozimek L., Daeschner J., O'Banion M.K., Weinberg G., Klockgether T., Feinstein D.L. Noradrenergic depletion potentiates beta-amyloid-induced cortical inflammation: implications for Alzheimer's disease. J. Neurosci. 2002, 22:2434-2442.
24. Heneka M.T., Gavrilyuk V., Landreth G.E., O'Banion M.K., Weinberg G., Feinstein D.L. Noradrenergic depletion increases inflammatory responses in brain: effects on IkappaB and HSP70 expression. J. Neurochem. 2003, 85:387-398.
25. (2+)]i. Neurochem. Int. 2010, 57:411-420.
26. Hess J., Angel P., Schorpp-Kistner M. AP-1 subunits: quarrel and harmony among siblings. J. Cell Sci. 2004, 117:5965-5973.
27. Hinojosa A.E., Garcia-Bueno B., Leza J.C., Madrigal J.L. CCL2/MCP-1 modulation of microglial activation and proliferation. J. Neuroinflammation 2011, 8:77.
28. Inazu M., Takeda H., Matsumiya T. Functional expression of the norepinephrine transporter in cultured rat astrocytes. J. Neurochem. 2003, 84:136-144.
29. Javaid J.I., Perel J.M., Davis J.M. Inhibition of biogenic amines uptake by imipramine, desipramine, 2 OH-imipramine and 2 OH-desipramine in rat brain. Life Sci. 1979, 24:21-28.
30. Juric D.M., Loncar D., Carman-Krzan M. Noradrenergic stimulation of BDNF synthesis in astrocytes: mediation via alpha1- and beta1/beta2-adrenergic receptors. Neurochem. Int. 2008, 52:297-306.
31. Kalinin S., Gavrilyuk V., Polak P.E., Vasser R., Zhao J., Heneka M.T., Feinstein D.L. Noradrenaline deficiency in brain increases beta-amyloid plaque burden in an animal model of Alzheimer's disease. Neurobiol. Aging 2007, 28:1206-1214.
32. Karpus W.J., Kennedy K.J. MIP-1alpha and MCP-1 differentially regulate acute and relapsing autoimmune encephalomyelitis as well as Th1/Th2 lymphocyte differentiation. J. Leukoc. Biol. 1997, 62:681-687.
33. Khorooshi R., Babcock A.A., Owens T. NF-kappaB-driven STAT2 and CCL2 expression in astrocytes in response to brain injury. J. Immunol. 2008, 181:7284-7291.
34. Kulkarni V.A., Jha S., Vaidya V.A. Depletion of norepinephrine decreases the proliferation, but does not influence the survival and differentiation, of granule cell progenitors in the adult rat hippocampus. Eur. J. Neurosci. 2002, 16:2008-2012.
35. Madrigal J.L., Feinstein D.L., Dello R.C. Norepinephrine protects cortical neurons against microglial-induced cell death. J. Neurosci. Res. 2005, 81:390-396.
36. Madrigal J.L., Dello R.C., Gavrilyuk V., Feinstein D.L. Effects of noradrenaline on neuronal NOS2 expression and viability. Antioxid. Redox Signal. 2006, 8:885-892.
37. Madrigal J.L., Leza J.C., Polak P., Kalinin S., Feinstein D.L. Astrocyte-derived MCP-1 mediates neuroprotective effects of noradrenaline. J. Neurosci. 2009, 29:263-267.
38. Madrigal J.L., Garcia-Bueno B., Hinojosa A.E., Polak P., Feinstein D.L., Leza J.C. Regulation of MCP-1 production in brain by stress and noradrenaline-modulating drugs. J. Neurochem. 2010, 113:543-551.
39. Magistretti P.J. Regulation of glycogenolysis by neurotransmitters in the central nervous system. Diabetes Metab. 1988, 14:237-246.
40. Malberg J.E., Eisch A.J., Nestler E.J., Duman R.S. Chronic antidepressant treatment increases neurogenesis in adult rat hippocampus. J. Neurosci. 2000, 20:9104-9110.
41. Marien M.R., Colpaert F.C., Rosenquist A.C. Noradrenergic mechanisms in neurodegenerative diseases: a theory. Brain Res. Brain Res. Rev. 2004, 45:38-78.
42. Morin D., Sapena R., Zini R., Onteniente B., Tillement J.P. Characterization of beta-adrenergic receptors of freshly isolated astrocytes and neurons from rat brain. Life Sci. 1997, 60:315-324.
43. Papay R., Gaivin R., McCune D.F., Rorabaugh B.R., Macklin W.B., McGrath J.C., Perez D.M. Mouse alpha1B-adrenergic receptor is expressed in neurons and NG2 oligodendrocytes. J. Comp. Neurol. 2004, 478:1-10.
44. Renauld A.E., Ignatowski T.A., Spengler R.N. Alpha 2-adrenergic receptor inhibition of cAMP accumulation is transformed to facilitation by tumor necrosis factor-alpha. Brain Res. 2004, 1004:212-216.
45. Salm A.K., McCarthy K.D. Expression of beta-adrenergic receptors by astrocytes isolated from adult rat cortex. Glia 1989, 2:346-352.
46. Santarelli L., Saxe M., Gross C., Surget A., Battaglia F., Dulawa S., Weisstaub N., Lee J., Duman R., Arancio O., Belzung C., Hen R. Requirement of hippocampal neurogenesis for the behavioral effects of antidepressants. Science 2003, 301:805-809.
47. Schwartz J.P., Nishiyama N. Neurotrophic factor gene expression in astrocytes during development and following injury. Brain Res. Bull. 1994, 35:403-407.
48. Selmeczy Z., Szelenyi J., Vizi E.S. Intact noradrenaline transporter is needed for the sympathetic fine-tuning of cytokine balance. Eur. J. Pharmacol. 2003, 469:175-181.
49. Semple B.D., Frugier T., Morganti-Kossmann M.C. CCL2 modulates cytokine production in cultured mouse astrocytes. J. Neuroinflammation 2010, 7:67.
50. Sharma S., Yang B., Xi X., Grotta J.C., Aronowski J., Savitz S.I. IL-10 directly protects cortical neurons by activating PI-3 kinase and STAT-3 pathways. Brain Res. 2011, 1373:189-194.
51. Sokolova A., Hill M.D., Rahimi F., Warden L.A., Halliday G.M., Shepherd C.E. Monocyte chemoattractant protein-1 plays a dominant role in the chronic inflammation observed in Alzheimer's disease. Brain Pathol. 2009, 19:392-398.
52. Stoll G., Jander S., Schroeter M. Cytokines in CNS disorders: neurotoxicity versus neuroprotection. J. Neural Transm. Suppl. 2000, 59:81-89.
53. Subhash M.N., Nagaraja M.R., Sharada S., Vinod K.Y. Cortical alpha-adrenoceptor downregulation by tricyclic antidepressants in the rat brain. Neurochem. Int. 2003, 43:603-609.
54. Szelenyi J., Kiss J.P., Puskas E., Selmeczy Z., Szelenyi M., Vizi E.S. Opposite role of alpha2- and beta-adrenoceptors in the modulation of interleukin-10 production in endotoxaemic mice. Neuroreport 2000, 11:3565-3568.
55. Tanaka K.F., Kashima H., Suzuki H., Ono K., Sawada M. Existence of functional beta1- and beta2-adrenergic receptors on microglia. J. Neurosci. Res. 2002, 70:232-237.
56. Thompson W.L., Karpus W.J., Van Eldik L.J. MCP-1-deficient mice show reduced neuroinflammatory responses and increased peripheral inflammatory responses to peripheral endotoxin insult. J. Neuroinflammation. 2008, 5:35.
57. Tjurmina O.A., Goldstein D.S., Palkovits M., Kopin I.J. Alpha2-adrenoceptor-mediated restraint of norepinephrine synthesis, release, and turnover during immobilization in rats. Brain Res. 1999, 826:243-252.
58. Ueda A., Ishigatsubo Y., Okubo T., Yoshimura T. Transcriptional regulation of the human monocyte chemoattractant protein-1 gene. Cooperation of two NF-kappaB sites and NF-kappaB/Rel subunit specificity. J. Biol. Chem. 1997, 272:31092-31099.
59. Widera D., Holtkamp W., Entschladen F., Niggemann B., Zanker K., Kaltschmidt B., Kaltschmidt C. MCP-1 induces migration of adult neural stem cells. Eur. J. Cell Biol. 2004, 83:381-387.
60. Yang G., Meng Y., Li W., Yong Y., Fan Z., Ding H., Wei Y., Luo J., Ke Z.J. Neuronal MCP-1 mediates microglia recruitment and neurodegeneration induced by the mild impairment of oxidative metabolism. Brain Pathol. 2010.
61. Zhang H.T., Whisler L.R., Huang Y., Xiang Y., O'Donnell J.M. Postsynaptic alpha-2 adrenergic receptors are critical for the antidepressant-like effects of desipramine on behavior. Neuropsychopharmacology 2009, 34:1067-1077.
62. Zhou Z., Zhen J., Karpowich N.K., Goetz R.M., Law C.J., Reith M.E., Wang D.N. LeuT-desipramine structure reveals how antidepressants block neurotransmitter reuptake. Science 2007, 317:1390-1393.